Mauro Salvi

Scopus Author ID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 16

Top Venues

International journal of molecular sciences

Cellular and molecular life sciences : CMLS

Cell death discovery

Chemical communications (Cambridge, England)

Mauro Salvi

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Mauro Salvi Dec 01 2015

Italy

Associate Professor :: Biomedical Sciences

Publications

Tsukasa Okiyoneda, Christian Borgo, Valentina Bosello Travain, Nicoletta Pedemonte, Mauro Salvi
Targeting ubiquitination machinery in cystic fibrosis: Where do we stand? Cellular and molecular life sciences : CMLS 81 (1) (2024)
Tsukasa Okiyoneda, Christian Borgo, Valentina Bosello Travain, Nicoletta Pedemonte, Mauro Salvi
Targeting ubiquitination machinery in cystic fibrosis: Where do we stand? Cellular and molecular life sciences : CMLS 81 (1) (2024)
Christian Borgo, Claudio D'Amore, Valeria Capurro, Valeria Tomati, Nicoletta Pedemonte, Valentina Bosello Travain, Mauro Salvi
SUMOylation Inhibition Enhances Protein Transcription under CMV Promoter: A Lesson from a Study with the F508del-CFTR Mutant. International journal of molecular sciences 25 (4) (2024)
Christian Borgo, Claudio D'Amore, Valeria Capurro, Valeria Tomati, Nicoletta Pedemonte, Valentina Bosello Travain, Mauro Salvi
SUMOylation Inhibition Enhances Protein Transcription under CMV Promoter: A Lesson from a Study with the F508del-CFTR Mutant. International journal of molecular sciences 25 (4) (2024)
Christian Borgo, Claudio D'Amore, Valeria Capurro, Valeria Tomati, Nicoletta Pedemonte, Valentina Bosello Travain, Mauro Salvi
SUMOylation Inhibition Enhances Protein Transcription under CMV Promoter: A Lesson from a Study with the F508del-CFTR Mutant. International journal of molecular sciences 25 (4) (2024)
Christian Borgo, Claudio D'Amore, Valeria Capurro, Valeria Tomati, Nicoletta Pedemonte, Valentina Bosello Travain, Mauro Salvi
SUMOylation Inhibition Enhances Protein Transcription under CMV Promoter: A Lesson from a Study with the F508del-CFTR Mutant. International journal of molecular sciences 25 (4) (2024)
Tsukasa Okiyoneda, Christian Borgo, Valentina Bosello Travain, Nicoletta Pedemonte, Mauro Salvi
Targeting ubiquitination machinery in cystic fibrosis: Where do we stand? Cellular and molecular life sciences : CMLS 81 (1) (2024)
Eleanor L Atkinson, Jessica Iegre, Claudio D'Amore, Paul D Brear, Mauro Salvi, Marko Hyvönen, David R Spring
Development of small cyclic peptides targeting the CK2α/β interface. Chemical communications (Cambridge, England) 58 (30) (2022)
Christian Borgo, Claudio D'Amore, Valeria Capurro, Valeria Tomati, Elvira Sondo, Federico Cresta, Carlo Castellani, Nicoletta Pedemonte, Mauro Salvi
Targeting the E1 ubiquitin-activating enzyme (UBA1) improves elexacaftor/tezacaftor/ivacaftor efficacy towards F508del and rare misfolded CFTR mutants. Cellular and molecular life sciences : CMLS 79 (4) (2022)
Claudio D'Amore, Christian Borgo, Valentina Bosello Travain, Mauro Salvi
KDM2A and KDM3B as Potential Targets for the Rescue of F508del-CFTR. International journal of molecular sciences 23 (17) (2022)
Francesca Zonta, Christian Borgo, Camila Paz Quezada Meza, Ionica Masgras, Andrea Rasola, Mauro Salvi, Lorenzo A Pinna, Maria Ruzzene
Contribution of the CK2 Catalytic Isoforms α and α' to the Glycolytic Phenotype of Tumor Cells. Cells 10 (1) (2021)
Claudio D'Amore, Mauro Salvi
Editorial of Special Issue "Protein Post-Translational Modifications in Signal Transduction and Diseases". International journal of molecular sciences 22 (5) (2021)
Mauro Salvi, Christian Borgo, Lorenzo A Pinna, Maria Ruzzene
Targeting CK2 in cancer: a valuable strategy or a waste of time? Cell death discovery 7 (1) (2021)
Christian Borgo, Claudio D'Amore, Luca Cesaro, Stefania Sarno, Lorenzo A Pinna, Maria Ruzzene, Mauro Salvi
How can a traffic light properly work if it is always green? The paradox of CK2 signaling. Critical reviews in biochemistry and molecular biology 56 (4) (2021)
Claudio D'Amore, Christian Borgo, Stefania Sarno, Mauro Salvi
Role of CK2 inhibitor CX-4945 in anti-cancer combination therapy - potential clinical relevance. Cellular oncology (Dordrecht) 43 (6) (2020)
Antonella Lettieri, Christian Borgo, Luca Zanieri, Claudio D'Amore, Roberto Oleari, Alyssa Paganoni, Lorenzo A Pinna, Alessia Caramello, Mauro Salvi
Protein Kinase CK2 Subunits Differentially Perturb the Adhesion and Migration of GN11 Cells: A Model of Immature Migrating Neurons. International journal of molecular sciences 20 (23) (2019)

Mauro Salvi.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Mauro Salvi